Randomized Controlled Trial of Transoral Incisionless Fundoplication Vs. Proton Pump Inhibitors for Treatment of Gastroesophageal Reflux Disease

1SurgOne Foregut Institute, Englewood, Colorado, USA Correspondence: Reginald C.W. Bell, MD, FACS, SurgOne Foregut Institute, 401 W Hampden Place Suite 230, Englewood, Colorado 80110, USA. E-mail: [email protected] Guarantor of the article: Reginald C.W. Bell, MD, FACS. Specific author contributions: Reginald C.W. Bell, MD, FACS is the sole author. Financial support: None. Potential competing interests: Research grants from and serves on the Scientific Advisory Board of EndoGastric Solutions, Inc. (Redmond, WA). I have carried out consulting for EndoGastric Solutions, the manufacturer of the device used in the above-referenced studies. I make no apology for this relationship—it is only through working with device manufacturers that the technique can be perfected and the devices improved. I assure that any compensation received for consulting does not even begin to offset the costs of being away from my patient practice.